TAGLIAFICO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 28.906
AS - Asia 14.006
EU - Europa 13.626
SA - Sud America 1.923
Continente sconosciuto - Info sul continente non disponibili 445
AF - Africa 386
OC - Oceania 73
Totale 59.365
Nazione #
US - Stati Uniti d'America 28.268
SG - Singapore 3.991
GB - Regno Unito 3.850
CN - Cina 3.338
IT - Italia 3.189
HK - Hong Kong 1.940
VN - Vietnam 1.601
BR - Brasile 1.436
SE - Svezia 1.372
DE - Germania 1.155
BD - Bangladesh 688
RU - Federazione Russa 649
FI - Finlandia 646
FR - Francia 624
TR - Turchia 462
KR - Corea 427
UA - Ucraina 419
NL - Olanda 408
IN - India 371
CA - Canada 359
ID - Indonesia 270
IE - Irlanda 233
BG - Bulgaria 193
SI - Slovenia 158
AR - Argentina 156
MX - Messico 134
JP - Giappone 132
IQ - Iraq 131
PL - Polonia 118
ZA - Sudafrica 110
ES - Italia 101
PK - Pakistan 88
BE - Belgio 79
EC - Ecuador 79
CO - Colombia 75
CZ - Repubblica Ceca 67
AE - Emirati Arabi Uniti 65
AU - Australia 64
CL - Cile 61
IR - Iran 58
MA - Marocco 57
AT - Austria 55
LT - Lituania 55
MY - Malesia 54
KE - Kenya 48
SA - Arabia Saudita 45
UZ - Uzbekistan 40
EG - Egitto 39
VE - Venezuela 38
TN - Tunisia 37
CH - Svizzera 36
PH - Filippine 30
GR - Grecia 29
IL - Israele 28
NP - Nepal 28
RO - Romania 28
TW - Taiwan 28
PY - Paraguay 27
CR - Costa Rica 26
JM - Giamaica 26
QA - Qatar 21
PE - Perù 20
TH - Thailandia 20
AZ - Azerbaigian 19
EU - Europa 19
DZ - Algeria 18
JO - Giordania 18
RS - Serbia 17
TT - Trinidad e Tobago 17
HU - Ungheria 16
PT - Portogallo 16
NO - Norvegia 15
UY - Uruguay 15
KG - Kirghizistan 14
OM - Oman 14
BO - Bolivia 13
DK - Danimarca 13
MD - Moldavia 13
BH - Bahrain 12
AL - Albania 11
KZ - Kazakistan 11
NI - Nicaragua 11
PA - Panama 11
HN - Honduras 10
SN - Senegal 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
GE - Georgia 9
HR - Croazia 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
SV - El Salvador 9
SY - Repubblica araba siriana 9
XK - ???statistics.table.value.countryCode.XK??? 9
BY - Bielorussia 8
KW - Kuwait 8
MK - Macedonia 8
GH - Ghana 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
Totale 58.819
Città #
Ashburn 2.927
Southend 2.721
Singapore 2.496
Santa Clara 2.488
Fairfield 2.414
Hong Kong 1.881
Chandler 1.517
Woodbridge 1.469
San Jose 1.448
Houston 1.125
Seattle 884
Council Bluffs 842
Hefei 828
Ann Arbor 806
Nyköping 775
Wilmington 749
Cambridge 739
Beijing 718
Jacksonville 693
Dearborn 622
London 574
Los Angeles 532
Chicago 530
Ho Chi Minh City 482
Modena 477
Helsinki 443
Seoul 402
New York 394
Hanoi 384
The Dalles 357
Milan 282
San Diego 272
Amsterdam 271
Izmir 229
Dublin 224
Salt Lake City 208
Jakarta 199
Munich 194
Princeton 191
Sofia 190
Buffalo 173
Lauterbourg 170
Moscow 168
Shanghai 166
Dallas 153
Bologna 151
São Paulo 142
Eugene 138
Rome 132
Fremont 113
Tampa 113
Columbus 111
Elk Grove Village 107
Orem 107
Frankfurt am Main 104
Tokyo 95
Toronto 95
Bremen 94
Sunnyvale 92
Da Nang 78
Falls Church 76
Des Moines 75
Boardman 74
Phoenix 74
Redwood City 71
Warsaw 71
Montreal 70
Atlanta 69
Denver 69
Reggio Emilia 67
Brussels 66
Turku 65
Johannesburg 60
Parma 60
Haiphong 59
Nuremberg 56
Chennai 55
Brooklyn 53
Dong Ket 53
Guangzhou 51
Baghdad 50
Mexico City 48
Lancaster 47
Sterling 46
Florence 44
Miami 44
Rio de Janeiro 44
Naples 42
Brno 41
Poplar 41
Ottawa 40
San Francisco 40
Verona 40
Biên Hòa 39
Stockholm 39
Turin 39
Manchester 38
Palermo 38
Brasília 36
Boston 35
Totale 39.604
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 576
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 567
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 518
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 495
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 483
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 469
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 458
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 458
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 458
The barley Frost resistance-H2 locus 450
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 439
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 429
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 420
NF-YA splice variants have different roles on muscle differentiation 420
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 420
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 420
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 404
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 404
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 403
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 401
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 400
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 395
Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic microenvironment 393
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 391
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 391
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 387
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 379
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 378
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 378
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 377
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 376
Mutations and prognosis in primary myelofibrosis 376
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 376
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 375
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 374
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 374
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 372
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 368
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 366
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial 364
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 360
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 360
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 357
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 355
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 355
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 355
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 353
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 349
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 346
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 346
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 345
Gene expression in grapevine cultivars in response to BOIS NOIR phytoplasma infection 345
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 343
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 340
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 339
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 332
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 331
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 330
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 328
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 327
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 327
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 323
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 322
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 321
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 320
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 319
Polarization dictates iron handling by inflammatory and alternatively activated macrophages 314
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 314
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 314
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 313
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 312
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 312
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 306
TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts 304
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 304
Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles 303
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 303
Gene expression profiling in MDS and AML: potential and future avenues 302
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. 302
HGM 2010 Programme / Abstract 302
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 301
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 301
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 301
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 298
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 298
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 297
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 296
Identification of new p63 targets in human keratinocytes 295
Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle 295
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 293
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 290
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 285
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 283
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 282
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 279
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 278
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy 277
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 277
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 276
Bile acid structure and regulation of biliary protein secretion and composition in man 275
Totale 35.592
Categoria #
all - tutte 227.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.773 0 393 391 237 179 251 210 178 401 340 670 523
2022/20234.808 547 595 503 418 516 590 112 432 656 51 194 194
2023/20243.131 117 148 220 259 487 284 387 415 91 124 202 397
2024/202510.174 311 136 226 617 1.859 1.462 841 626 1.192 456 1.150 1.298
2025/202620.243 1.393 841 1.459 2.308 3.455 1.321 2.456 921 1.839 1.886 1.340 1.024
2026/20271.851 642 1.209 0 0 0 0 0 0 0 0 0 0
Totale 59.365